Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas S Hopkinson

Showing results (251-260 of 291) with videos related to

Pageof 30
Sort By:
The European Respiratory Journal|December 20, 2023
Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trialAli M Alasmari, Abdullah S Alsulayyim, Saeed M Alghamdi, et al.
The Lancet. Respiratory Medicine|April 30, 2022
An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trialKeir E J Philip, Harriet Owles, Stephanie McVey, et al.
The European Respiratory Journal|February 25, 2012
Quadriceps wasting and physical inactivity in patients with COPDDinesh Shrikrishna, Mehul Patel, Rebecca J Tanner, et al.
Plos One|March 23, 2018
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trialMarie Fisk, Joseph Cheriyan, Divya Mohan, et al.
Thorax|January 6, 2021
Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million peopleNicholas S Hopkinson, Niccolo Rossi, Julia El-Sayed Moustafa, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 31, 2016
Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivoMehul S Patel, Jen Lee, Manuel Baz, et al.
ERJ Open Research|September 3, 2021
Quantitative <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPDLaurence Vass, Marie Fisk, Joseph Cheriyan, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|April 24, 2024
Gait differences between COPD and healthy controls: systematic review and meta-analysisJoren Buekers, Laura Delgado-Ortiz, Dimitrios Megaritis, et al.
Thorax|February 8, 2025
Dietary nitrate supplementation enhances exercise capacity in WHO Group 3 pulmonary hypertension: a double-blind, placebo-controlled, randomised crossover study (EDEN-OX2)Abdullah S Alsulayyim, Ali M Alasmari, Laura C Price, et al.
Chronic Respiratory Disease|September 2, 2023
Development and implementation of the lung volume reduction pulmonary rehabilitation tool to identify eligibility for lung volume reduction in people with chronic obstructive pulmonary disease during pulmonary rehabilitationSara C Buttery, Parris J Williams, Lisa J Brighton, et al.
Pageof 30

Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
The European Respiratory Journal|December 20, 2023
Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trialAli M Alasmari, Abdullah S Alsulayyim, Saeed M Alghamdi, et al.
The Lancet. Respiratory Medicine|April 30, 2022
An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trialKeir E J Philip, Harriet Owles, Stephanie McVey, et al.
The European Respiratory Journal|February 25, 2012
Quadriceps wasting and physical inactivity in patients with COPDDinesh Shrikrishna, Mehul Patel, Rebecca J Tanner, et al.
Plos One|March 23, 2018
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trialMarie Fisk, Joseph Cheriyan, Divya Mohan, et al.
Thorax|January 6, 2021
Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million peopleNicholas S Hopkinson, Niccolo Rossi, Julia El-Sayed Moustafa, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 31, 2016
Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivoMehul S Patel, Jen Lee, Manuel Baz, et al.
ERJ Open Research|September 3, 2021
Quantitative <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPDLaurence Vass, Marie Fisk, Joseph Cheriyan, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|April 24, 2024
Gait differences between COPD and healthy controls: systematic review and meta-analysisJoren Buekers, Laura Delgado-Ortiz, Dimitrios Megaritis, et al.
Thorax|February 8, 2025
Dietary nitrate supplementation enhances exercise capacity in WHO Group 3 pulmonary hypertension: a double-blind, placebo-controlled, randomised crossover study (EDEN-OX2)Abdullah S Alsulayyim, Ali M Alasmari, Laura C Price, et al.
Chronic Respiratory Disease|September 2, 2023
Development and implementation of the lung volume reduction pulmonary rehabilitation tool to identify eligibility for lung volume reduction in people with chronic obstructive pulmonary disease during pulmonary rehabilitationSara C Buttery, Parris J Williams, Lisa J Brighton, et al.
Pageof 30